Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDAC Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02213861
What this trial is testing

Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T-Cell Lymphoma (CTCL)
TetraLogic Pharmaceuticals 60
Early research (Phase 1)Study completedNCT01583283
What this trial is testing

Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 38
Very early researchWithdrawnNCT03022565
What this trial is testing

Vorinostat in Patients With Class 2 High Risk Uveal Melanoma

Who this might be right for
Uveal Melanoma
University of Miami
Early research (Phase 1)Ended earlyNCT01174199
What this trial is testing

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer+2 more
Roswell Park Cancer Institute 13
Early research (Phase 1)Study completedNCT02922933
What this trial is testing

Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects

Who this might be right for
VolunteersHealthy VolunteersHuman Volunteers+1 more
Syndax Pharmaceuticals 66
Testing effectiveness (Phase 2)Ended earlyNCT01582009
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more
Roswell Park Cancer Institute 26
Early research (Phase 1)Looking for participantsNCT01245179
What this trial is testing

Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Abdullah Kutlar 18
Early research (Phase 1)Study completedNCT01742988
What this trial is testing

Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma

Who this might be right for
LymphomaRelapsed LymphomaRefractory Lymphoma+8 more
Curis, Inc. 106
Testing effectiveness (Phase 2)Ended earlyNCT03713320
What this trial is testing

SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides

Who this might be right for
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
miRagen Therapeutics, Inc. 37
Testing effectiveness (Phase 2)Ended earlyNCT01947140
What this trial is testing

Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies

Who this might be right for
Lymphoid MalignanciesMultiple MyelomaLymphoma+2 more
Jennifer Amengual 57
Testing effectiveness (Phase 2)UnknownNCT05411380
What this trial is testing

Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.

Who this might be right for
Breast Cancer
wang shusen 73
Not applicableEnded earlyNCT01543074
What this trial is testing

Dietary Histone Deacetylase Inhibitors (HDAC)

Who this might be right for
Histone Deacetylase (HDAC) Activity
Texas A&M University 23
Testing effectiveness (Phase 2)Ended earlyNCT00567879
What this trial is testing

A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 56
Testing effectiveness (Phase 2)UnknownNCT02149160
What this trial is testing

Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation

Who this might be right for
Granulin Mutation
FORUM Pharmaceuticals Inc 30
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00570284
What this trial is testing

Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors

Who this might be right for
Cancer
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Looking for participantsNCT07136181
What this trial is testing

Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal MelanomaUveal Melanoma, MetastaticUveal Melanoma, Recurrent+2 more
Novelwise Pharmaceutical Corporation 36